• Rahilly-Tierney C, Walton SM. Cost-effectiveness of the 70-gene signature versus adjuvant!online and systematic chemotherapy for risk stratification of patients with node-negative breast cancer: does accuracy matter? J Clin Oncol. 2015; 33(14):1628-9.
• Rahilly-Tierney C, Sesso HD, Michael Gaziano J, Djousse L. High-density lipoprotein and mortality before age 90 in male physicians. Circ Cardiovasc Qual Outcomes. 2012; 5(3):381-6.
• Rahilly-Tierney C, Vokonas P, Gaziano JM, Spiro A 3rd. Lifestyle change and high-density lipoprotein change: the US Department of Veterans Affairs Normative Aging Study. Clin Cardiol. 2012; 35(7):437-42.
• Robinson JG, Rahilly-Tierney C, Lawlaer E, Gaziano JM. Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men. J Clin Lipidol. 2012; 6(1):58-65.
• Rahilly-Tierney CR, Arnett DK, North KE, Pankow JS, Hunt SC, Ellison RC, Gaziano JM, Djousse L. Apolipoprotein Ɛ4 polymorphism does not modify the association between body mass index and high-density lipoprotein cholesterol: a cross-sectional cohort study. Lipids Health Dis. 2011; 10:167.
• Rahilly-Tierney C, Sesso HD, Djousse L, Gaziano JM. Lifestyle changes and 14-year change in high-density lipoprotein cholesterol in a cohort of male physicians. Am Heart J. 2011; 161(4):12-18.
• Rahilly-Tierney CR, Spiro A 3rd, Vokonas P, Gaziano JM. Relation between high-density lipoprotein cholesterol and survival to age 85 years in men (from the VA Normative Aging Study). Am J Cardiol. 2011; 107(8):1173-7.
• Rahilly-Tierney CR, Lawler EV, Scranton RE, Gaziano JM. Cardiovascular benefit of magnitude of low-density lipoprotein cholesterol reduction: a comparison of subgroups by age. Circulation. 2009; 120(15):1491-7.
• Rahilly-Tierney CR, Lawler EV, Scranton RE, Michael Gaziano J. Low-density lipoprotein reduction and magnitude of cardiovascular risk reduction. Prev Cardiol. 2009; 12(2):80-7.
• Rahilly-Tierney C, Bowman TS, Djousse L, Sesso HD, Gaziano JM. Change in high-density lipoprotein cholesterol and incident coronary heart disease in apparently healthy male physicians. Am J Cardiol. 2008; 102(12):1663-7.
• Rahilly-Tierney CR, Nash IS. Decision-making in percutaneous coronary intervention: a survey. BMC Med Inform Decis Mak. 2008; 8:28.